Description
Manfaro-300 is a Faropenem Extended Release tablet formulation, a broad-spectrum oral penem antibiotic positioned for bacterial infection management. It is a prescription antibiotic, part of Manfaith’s anti-infective product range.
Composition & Strength
Faropenem (Extended Release) 300 mg (Tablets)
Key Formulation Component and Its Role
- Faropenem – A broad-spectrum oral penem antibiotic with activity against a wide range of Gram-positive and Gram-negative bacteria; the extended-release formulation is designed to help maintain drug levels for prolonged antibacterial action, supporting bactericidal action through inhibition of bacterial cell wall synthesis against susceptible respiratory, urinary, skin and soft tissue pathogens
Indications / Medical Uses
- Respiratory tract infections
- Urinary tract infections
- Skin and soft tissue infections
- Ear, Nose & Throat (ENT) infections
Packaging & Key Features
- Available as extended-release tablets, 6×10 pack
- Extended-release formulation designed for sustained release of the active ingredient
- Prescription product (Rx) intended for use under medical supervision
Manfaro-300 for PCD Pharma Franchise
Manfaro-300 Tablets is part of Manfaith’s anti-infective product range and is available for PCD pharma franchise and third-party manufacturing partnerships in India. Its Faropenem extended-release formulation makes it a relevant addition to a PCD pharma franchise portfolio focused on antibiotic and anti-infective care for pharmaceutical distributors and franchise partners.
